The 2019 novel coronavirus (2019-nCoV) or the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) as it is now called, is rapidly spreading from its origin in Wuhan City of Hubei Province of China to the rest of the world.
D-dimer, Coagulopathy, T-wave inversion, COVID-19, LMWH
A 54-years old male patient came with fever one week, coughing white mucus and difficulty breathing. Thorax x-ray revealed infiltrate perihilar dextra-sinistra and cardiomegaly. Transferred to High Care Unit with SpO2 84%, respiratory rate 30/min. His laboratory WBC count 13.620, Limfosit 2, Ureum 55, Creatinine 0.5, SGOT 34, SGPT 129, Natrium 123, Chlorida 90, D-Dimer 7.852, and Procalcitonin 0.07. ECG revealed T inversion on L I, L II, L III, AVL, V-1, V-3, V-4. Hs-Troponin I result revealed 3.8. Treated with antiplatelet, lisinopril, bisoprolol and combining mechanical ventilator. Also with COVID-19 severe treatment protocols and others such as heparin, acetaminophen, acetylcysteine and curcuma. After 21 days in high care unit miraculously shows good outcome following another x-ray revealed reduce infiltration in both lungs (Figure 1 and Figure 2).
Hypercoagulation of SARS-CoV-2 involves a unique mechanism of thrombo-inflammation triggered by viral infection, originally in the pulmonary vasculature. Interestingly, ECG changes in T-Wave inversion although it is not associated with a troponin elevation. With severe symptoms COVID-19 in these segments may be an indicator of the underlying myocardial injury. Numerous studies have explored the benefit of using coagulation inhibitors such as intravenous or subcutaneous low-molecular-weight heparin (LMWH). In this case with intravenous heparin has been doing shows good outcomes and reducing infiltration in both lungs despite been high mortality condition [1-4].
Hypercoagulable state is challenging clinical problem in the form of venous and arterial thromboembolism, is emerging as one of the most severe sequelae of the disease, and has been prognostic of poorer outcomes. Death might occur due to progressive infection. Appropriate identification of ECG pattern could play an important role in identifying COVID-19 patients at higher risk of adverse events such as intubation and death.